Compound ID | 3389
AP-SA02
Synonym(s): APSA02 | AP SA02
Class: Bacteriophage
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus including methicillin- and vancomycin-resistant strains; intended indication for bacteraemia caused by Gram-positive pathogens |
| Description: | Bacteriophage with activity against Staphylococcus aureus biofilms |
| Institute where first reported: | Armata Pharmaceuticals |
| Year first mentioned: | 2021 |
| Highest developmental phase: | Phase 2 (NCT05184764) |
| Development status: | Active |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.